N@N

Kyle Rose Upgraded (ZBH) to Strong Buy and Increased Target to $167 on, Sep 18th, 2019

Kyle Rose of Canaccord Genuity, Upgraded "Zimmer Biomet Holdings, Inc." (ZBH) to Strong Buy and Increased Target from $137 to $167 on, Sep 18th, 2019.

Kyle has made no other calls on ZBH in the last 4 months.

There are 7 other peers that have a rating on ZBH. Out of the 7 peers that are also analyzing ZBH, 1 agrees with Kyle's Rating of Hold. Following is the relevant analyst calls for the last 4 months

---

• Travis Steed of "Barclays" Upgraded from Sell to Hold and Increased Target to $140 on, Tuesday, July 30th, 2019

These are the ratings of the 6 analyists that currently disagree with Kyle

---

• Larry Biegelsen of "Wells Fargo" Maintained at Buy with Increased Target to $158 on, Monday, September 9th, 2019
• David Toung of "Argus Research" Upgraded from Hold to Strong Buy on, Monday, August 12th, 2019
• Joanne Wuensch of "Citigroup" Maintained at Strong Buy with Increased Target to $158 on, Friday, August 2nd, 2019
• Lawrence Keusch of "Raymond James" Maintained at Buy with Increased Target to $150 on, Monday, July 29th, 2019
• David Lewis of "Morgan Stanley" Maintained at Buy with Increased Target to $150 on, Monday, July 29th, 2019
• Jeff Johnson of "Baird" Upgraded from Hold to Buy and Increased Target to $154 on, Monday, July 29th, 2019

Contributing Sources

---